Novartis Investigative Site

Hardwick, Stockton on Tees TS19 8PE

0 studies enrolling now · 3 studies all time

What they study most

Acute Heart Failure, Cardiovascular Disease and Lipoprotein(a), Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed